IPN01203
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPN01203, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies [Phase 1, Phase 2]